Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Cyproterone acetate therapy improved hair loss and reduced testosterone levels in a menopausal woman.

Treatments for PCOS aim to reduce androgen levels and improve insulin sensitivity to lower cardiometabolic risk.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Zinc and copper levels may affect erectile dysfunction by influencing hormone levels.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

Vitamin D may help improve hormone levels in women with PCOS.

The conclusion is that 24 weeks of low-dose oral minoxidil is safe for men with hair loss, with no significant changes in heart rate or blood pressure.

Leucine levels may affect hair loss after bariatric surgery.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

Girls with PCOS have higher levels of certain androgens, which are linked to excess hair growth, but these androgens don't help diagnose PCOS.

Statins may help treat PCOS by lowering androgen levels and improving cholesterol.

Lifestyle changes and environmental strategies can help address declining testosterone levels.

Patients with alopecia areata have higher oxidative stress and lower antioxidant levels.

SV40 T antigen in hair follicles causes abnormal hair and health issues in mice.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Hypoxic training didn't change skin features, but skin barrier function is linked to blood lipid levels.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

Finasteride may lower cholesterol and slow heart disease progression.

Going to bed late may increase hormones and decrease muscle in women with PCOS.

Vasodilators may worsen abdominal aortic aneurysm.

Autoimmune markers may help diagnose and manage PCOS.

Cholesterol affects coronavirus spread and could be a target for treatment.

Combining a plant-based diet with emotional intelligence can lower BMI and bad cholesterol.

Hair manganese may relate to cardiometabolic health, not coronary artery disease severity.

Early-onset male hair loss may be linked to higher cardiovascular risk.

Early balding in young Indian men may indicate a higher risk of metabolic syndrome and potential heart disease.

PCOS affects many women, causing hormonal issues and health risks, but can be managed with lifestyle changes and medication.

Early hair loss may predict heart disease.